Trichorzin PA V
| Internal ID | 41357699-198b-43d0-8ea5-cbfcb8e927f1 |
| Taxonomy | Organic Polymers > Polypeptides |
| IUPAC Name | 2-[[2-[[2-[[2-[[1-[2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[2-[[2-[(2-acetamido-2-methylpropanoyl)amino]-3-hydroxypropanoyl]amino]propanoylamino]-2-methylbutanoyl]amino]-2-methylbutanoyl]amino]-5-amino-5-oxopentanoyl]amino]-2-methylpropanoyl]amino]-3-methylbutanoyl]amino]-2-methylpropanoyl]amino]acetyl]amino]-4-methylpentanoyl]amino]-2-methylpropanoyl]pyrrolidine-2-carbonyl]amino]-4-methylpentanoyl]amino]-2-methylpropanoyl]amino]-2-methylpropanoyl]amino]-N-[1-hydroxy-3-(1H-indol-3-yl)propan-2-yl]pentanediamide |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C87H143N21O22/c1-25-86(23,107-78(129)87(24,26-2)105-64(115)48(9)92-66(117)58(44-110)98-73(124)81(13,14)100-49(10)111)77(128)97-55(34-36-61(89)113)67(118)101-82(15,16)75(126)99-63(47(7)8)71(122)104-80(11,12)72(123)91-42-62(114)94-56(38-45(3)4)68(119)103-85(21,22)79(130)108-37-29-32-59(108)70(121)95-57(39-46(5)6)69(120)102-84(19,20)76(127)106-83(17,18)74(125)96-54(33-35-60(88)112)65(116)93-51(43-109)40-50-41-90-53-31-28-27-30-52(50)53/h27-28,30-31,41,45-48,51,54-59,63,90,109-110H,25-26,29,32-40,42-44H2,1-24H3,(H2,88,112)(H2,89,113)(H,91,123)(H,92,117)(H,93,116)(H,94,114)(H,95,121)(H,96,125)(H,97,128)(H,98,124)(H,99,126)(H,100,111)(H,101,118)(H,102,120)(H,103,119)(H,104,122)(H,105,115)(H,106,127)(H,107,129) |
| InChI Key | YFOYNNCDKRBTEQ-UHFFFAOYSA-N |
| Popularity | 4 references in papers |
| Molecular Formula | C87H143N21O22 |
| Molecular Weight | 1835.20 g/mol |
| Exact Mass | 1834.07165527 g/mol |
| Topological Polar Surface Area (TPSA) | 657.00 Ų |
| XlogP | -0.60 |
| Atomic LogP (AlogP) | -3.06 |
| H-Bond Acceptor | 22 |
| H-Bond Donor | 22 |
| Rotatable Bonds | 51 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.9160 | 91.60% |
| Caco-2 | - | 0.8603 | 86.03% |
| Blood Brain Barrier | - | 0.7000 | 70.00% |
| Human oral bioavailability | - | 0.6571 | 65.71% |
| Subcellular localzation | Lysosomes | 0.5386 | 53.86% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8276 | 82.76% |
| OATP1B3 inhibitior | + | 0.9326 | 93.26% |
| MATE1 inhibitior | - | 0.7679 | 76.79% |
| OCT2 inhibitior | - | 0.9250 | 92.50% |
| BSEP inhibitior | + | 0.9701 | 97.01% |
| P-glycoprotein inhibitior | + | 0.7419 | 74.19% |
| P-glycoprotein substrate | + | 0.8723 | 87.23% |
| CYP3A4 substrate | + | 0.7576 | 75.76% |
| CYP2C9 substrate | + | 0.5775 | 57.75% |
| CYP2D6 substrate | - | 0.8178 | 81.78% |
| CYP3A4 inhibition | + | 0.5377 | 53.77% |
| CYP2C9 inhibition | - | 0.7750 | 77.50% |
| CYP2C19 inhibition | - | 0.6924 | 69.24% |
| CYP2D6 inhibition | - | 0.8838 | 88.38% |
| CYP1A2 inhibition | - | 0.8559 | 85.59% |
| CYP2C8 inhibition | + | 0.7943 | 79.43% |
| CYP inhibitory promiscuity | - | 0.8365 | 83.65% |
| UGT catelyzed | + | 0.6000 | 60.00% |
| Carcinogenicity (binary) | - | 0.7700 | 77.00% |
| Carcinogenicity (trinary) | Non-required | 0.6163 | 61.63% |
| Eye corrosion | - | 0.9872 | 98.72% |
| Eye irritation | - | 0.8954 | 89.54% |
| Skin irritation | - | 0.7872 | 78.72% |
| Skin corrosion | - | 0.9222 | 92.22% |
| Ames mutagenesis | - | 0.7178 | 71.78% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.7233 | 72.33% |
| Micronuclear | + | 0.7200 | 72.00% |
| Hepatotoxicity | + | 0.5254 | 52.54% |
| skin sensitisation | - | 0.8756 | 87.56% |
| Respiratory toxicity | + | 0.8222 | 82.22% |
| Reproductive toxicity | + | 0.9778 | 97.78% |
| Mitochondrial toxicity | + | 0.9625 | 96.25% |
| Nephrotoxicity | - | 0.8798 | 87.98% |
| Acute Oral Toxicity (c) | III | 0.6097 | 60.97% |
| Estrogen receptor binding | - | 0.5985 | 59.85% |
| Androgen receptor binding | + | 0.7352 | 73.52% |
| Thyroid receptor binding | + | 0.8029 | 80.29% |
| Glucocorticoid receptor binding | + | 0.8465 | 84.65% |
| Aromatase binding | + | 0.8250 | 82.50% |
| PPAR gamma | + | 0.7907 | 79.07% |
| Honey bee toxicity | - | 0.6907 | 69.07% |
| Biodegradation | - | 0.8750 | 87.50% |
| Crustacea aquatic toxicity | - | 0.5300 | 53.00% |
| Fish aquatic toxicity | + | 0.7910 | 79.10% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.92% | 98.95% |
| CHEMBL3837 | P07711 | Cathepsin L | 99.76% | 96.61% |
| CHEMBL220 | P22303 | Acetylcholinesterase | 99.41% | 94.45% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 99.35% | 91.11% |
| CHEMBL1914 | P06276 | Butyrylcholinesterase | 99.25% | 95.00% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 98.59% | 98.33% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 98.55% | 96.09% |
| CHEMBL3830 | Q2M2I8 | Adaptor-associated kinase | 98.04% | 83.10% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 97.40% | 97.09% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 96.35% | 97.64% |
| CHEMBL225 | P28335 | Serotonin 2c (5-HT2c) receptor | 95.39% | 89.62% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 94.17% | 97.23% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 94.15% | 93.56% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 93.89% | 97.14% |
| CHEMBL4816 | Q9Y243 | Serine/threonine-protein kinase AKT3 | 93.62% | 96.28% |
| CHEMBL4979 | P13866 | Sodium/glucose cotransporter 1 | 93.47% | 98.24% |
| CHEMBL230 | P35354 | Cyclooxygenase-2 | 93.39% | 89.63% |
| CHEMBL259 | P32245 | Melanocortin receptor 4 | 92.94% | 95.38% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 92.84% | 91.19% |
| CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 92.53% | 89.00% |
| CHEMBL333 | P08253 | Matrix metalloproteinase-2 | 92.50% | 96.31% |
| CHEMBL2535 | P11166 | Glucose transporter | 92.49% | 98.75% |
| CHEMBL3176 | O43603 | Galanin receptor 2 | 92.48% | 98.89% |
| CHEMBL5043 | Q6P179 | Endoplasmic reticulum aminopeptidase 2 | 92.40% | 91.81% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 92.05% | 100.00% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 91.94% | 95.56% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 91.92% | 96.47% |
| CHEMBL3155 | P34969 | Serotonin 7 (5-HT7) receptor | 91.73% | 90.71% |
| CHEMBL321 | P14780 | Matrix metalloproteinase 9 | 91.37% | 92.12% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 91.19% | 100.00% |
| CHEMBL1944495 | P28065 | Proteasome subunit beta type-9 | 91.14% | 97.50% |
| CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 91.14% | 82.69% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 91.01% | 96.00% |
| CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 90.70% | 98.94% |
| CHEMBL3310 | Q96DB2 | Histone deacetylase 11 | 89.55% | 88.56% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 89.40% | 94.66% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 89.11% | 90.08% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 89.11% | 88.42% |
| CHEMBL255 | P29275 | Adenosine A2b receptor | 89.07% | 98.59% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 87.98% | 95.89% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 87.61% | 100.00% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 87.54% | 93.10% |
| CHEMBL3476 | O15111 | Inhibitor of nuclear factor kappa B kinase alpha subunit | 87.19% | 95.83% |
| CHEMBL2730 | P21980 | Protein-glutamine gamma-glutamyltransferase | 86.95% | 92.38% |
| CHEMBL5939 | Q9NZ08 | Endoplasmic reticulum aminopeptidase 1 | 86.85% | 100.00% |
| CHEMBL1873 | P00750 | Tissue-type plasminogen activator | 86.52% | 93.33% |
| CHEMBL4101 | P17612 | cAMP-dependent protein kinase alpha-catalytic subunit | 86.43% | 82.86% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 85.78% | 96.90% |
| CHEMBL3729 | P22748 | Carbonic anhydrase IV | 85.69% | 99.23% |
| CHEMBL4625 | Q07817 | Apoptosis regulator Bcl-X | 85.11% | 99.77% |
| CHEMBL3430907 | Q96GD4 | Aurora kinase B/Inner centromere protein | 85.04% | 97.50% |
| CHEMBL4394 | Q9NYA1 | Sphingosine kinase 1 | 84.79% | 96.03% |
| CHEMBL5028 | O14672 | ADAM10 | 84.78% | 97.50% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 84.49% | 99.17% |
| CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 84.20% | 93.03% |
| CHEMBL2095164 | P49354 | Geranylgeranyl transferase type I | 83.65% | 92.80% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 82.15% | 98.05% |
| CHEMBL213 | P08588 | Beta-1 adrenergic receptor | 81.46% | 95.56% |
| CHEMBL4073 | P09237 | Matrix metalloproteinase 7 | 81.15% | 97.56% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 80.53% | 94.45% |
| CHEMBL4657 | Q6V1X1 | Dipeptidyl peptidase VIII | 80.52% | 97.21% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 139587217 |
| LOTUS | LTS0009664 |
| wikiData | Q77560586 |